Products for Research Use Only
RegisterLogin

Eluvixtamab

CAT: 0804-HY-P99910-01Size: 100 µgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99910-01Size:100 µg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Eluvixtamab (AMG-330) is a bispecific T-cell engager. Eluvixtamab binds to CD33 and CD3 on T cells, thereby promoting T cell-mediated cytotoxicity against CD33+ cells. Eluvixtamab can be used in the research of tumors such as relapsed/refractory acute myeloid leukemia[1].
CAS Number
1679391-73-1
Product Name Alternative
AMG-330
UNSPSC
12352203
Target
CD3; Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/eluvixtamab.html
Purity
97.28
Smiles
[Eluvixtamab]
Molecular Weight
(54.34 kDa)
References & Citations
[1]Ravandi F, et al. Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study. Leuk Lymphoma. 2024 Sep;65 (9) :1281-1291.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
T9901A-093-01Eluvixtamab
GTR18575782-01Eluvixtamab Antibody
E55B1270Eluvixtamab (Reference antibody)
591821CD33, Eluvixtamab Biosimilar
HB185046-01Research Grade Eluvixtamab
KBI1757KRIBIOLISA™ Eluvixtamab ELISA
GTR18697372-01Eluvixtamab Human Monoclonal Antibody
21-907Eluvixtamab - Research Grade Biosimilar
A135479Eluvixtamab Biosimilar (Monoclonal, (scFv-heavy-kappa) - (scFv-heavy-lambda) )
PX-TA1662-01Eluvixtamab Biosimilar - Anti-CD33; CD3E mAb - Research Grade

Popular Products